Transaction Details

January 7, 2021
Tokyo, Shanghai

Sector

Healthcare

Deal Type

Other

Deal Team

Toshiyuki Ikeda, Takashi Misato, Terry Li

Advisor to Harbin Pharma on its acquisition of Roxatidine China rights from ASKA Pharma

Related Transactions

Previous
All transactions